Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTaylor Wimpey Regulatory News (TW.)

Share Price Information for Taylor Wimpey (TW.)

Share Price is delayed by 15 minutes
Get Live Data
84.22    1.32 (1.59%)
Bid:
85.08
Ask:
85.18
Spread: 0.10 (0.118%)
Market Cap: £2.93b
TW. Live PriceLast checked at - London Stock Exchange

Intraday Taylor Wimpey Share Chart

Director/PDMR Shareholding

6 Mar 2026 11:44

RNS Number : 7142V
Taylor Wimpey PLC
06 March 2026
 

6 March 2026

Taylor Wimpey plc

Director/PDMR Dealing

The Directors named below have acquired a further interest in the Ordinary Shares of 1 pence each in Taylor Wimpey plc (the 'Company') as a result of exercising their 2023 Taylor Wimpey Performance Share Plan Award and selling sufficient shares to meet tax and commission charges. The balance of shares will be retained by each Director for two years in the Company's Employee Benefit Trust, in accordance with the Company's Remuneration Policy.

In accordance with the requirements of Article 19 of the UK Market Abuse Regulation, detailed information is set out below.

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1

 

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Jennie Daly

 

2

Reason for the notification

a)

Position/status

Chief Executive

b)

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Taylor Wimpey plc

b)

LEI

21380089BTRXTD8S3R66

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

Transaction 1

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares of 1 pence each

 

 

GB0008782301

 

b)

 

Nature of the transaction

 

Acquisition of shares following the exercise of an Award under the Taylor Wimpey Performance Share Plan

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

Nil

1,040,748

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

N/A

e)

 

Date of the transaction

5 March 2026

f)

 

Place of the transaction

Private transaction

 

Transaction 2

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares of 1 pence each

 

 

 

GB0008782301

 

b)

 

Nature of the transaction

 

 

Sale of shares to meet tax and commission charges due following exercise of Award under the Taylor Wimpey Performance Share Plan

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

£1.0105

490,379

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

490,379

 

£1.0105

e)

 

Date of the transaction

 

 

5 March 2026

f)

 

Place of the transaction

 

 

London Stock Exchange (XLON)

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Chris Carney

 

2

Reason for the notification

a)

Position/status

Group Finance Director

b)

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Taylor Wimpey plc

b)

LEI

21380089BTRXTD8S3R66

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

Transaction 1

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares of 1 pence each

 

 

GB0008782301

 

b)

 

Nature of the transaction

 

 

Acquisition of shares following exercise of an Award under the Taylor Wimpey Performance Share Plan

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

Nil

700,354

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

N/A

e)

 

Date of the transaction

5 March 2026

f)

 

Place of the transaction

Private transaction

 

Transaction 2

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 1 pence each

 

 

GB0008782301

b)

 

Nature of the transaction

 

 

Sale of shares to meet tax and commission charges due following exercise of Awards under the Taylor Wimpey Performance Share Plan

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

£1.0105

329,993

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

329,993

 

£1.0105

e)

 

Date of the transaction

 

 

5 March 2026

f)

 

Place of the transaction

 

 

London Stock Exchange (XLON)

 

-Ends-

 

For further information please contact:

 

Taylor Wimpey plc

Ishaq Kayani, Group General Counsel and Company Secretary Tel: +44 (0) 1494 558323

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHSSEFFMEMSELD
Date   Source Headline
1st Dec 202512:03 pmRNSTotal Voting Rights
18th Nov 20253:47 pmRNSDirector/PDMR Shareholding
12th Nov 20257:00 amRNSTrading Statement
11th Nov 202512:07 pmRNSDirector/PDMR Shareholding
3rd Nov 20254:26 pmRNSTotal Voting Rights
17th Oct 20253:33 pmRNSPurchase of Shares by the Employee Benefit Trust
10th Oct 20259:27 amRNSDirector/PDMR Shareholding
1st Oct 202510:38 amRNSTotal Voting Rights
1st Oct 20257:00 amRNSInvestor and analyst update and trading statement
9th Sep 20254:18 pmRNSDirector/PDMR Shareholding
1st Sep 20258:00 amRNSTotal Voting Rights
11th Aug 20252:49 pmRNSDirector/PDMR Shareholding
1st Aug 202511:09 amRNSTotal Voting Rights
30th Jul 20257:00 amRNSHalf year results 2025
9th Jul 202512:43 pmRNSDirector/PDMR Shareholding
9th Jul 20258:05 amRNSCMA consults on proposed commitments
7th Jul 202512:43 pmRNSDirector Declaration
1st Jul 202511:32 amRNSBlock listing Interim Review
1st Jul 202511:30 amRNSBlock listing Interim Review
1st Jul 202511:10 amRNSTotal Voting Rights
23rd Jun 202510:34 amRNSHolding(s) in Company
10th Jun 20254:18 pmRNSDirector/PDMR Shareholding
2nd Jun 20251:28 pmRNSTotal Voting Rights
28th May 20254:27 pmRNSDirector/PDMR Shareholding
16th May 20258:55 amRNSHolding(s) in Company
15th May 20252:34 pmRNSDirector/PDMR Shareholding
13th May 20259:34 amRNSDirector/PDMR Shareholding
12th May 20251:24 pmRNSDirector/PDMR Shareholding
1st May 20253:51 pmRNSTotal Voting Rights
1st May 20259:22 amRNSHolding(s) in Company
30th Apr 20253:14 pmRNSResult of AGM
30th Apr 20257:00 amRNSTrading Statement
29th Apr 20254:26 pmRNSHolding(s) in Company
10th Apr 20254:36 pmRNSDirector/PDMR Shareholding
1st Apr 20253:48 pmRNSTotal Voting Rights
28th Mar 20252:20 pmRNSHolding(s) in Company
25th Mar 20252:47 pmRNSAnnual Financial Report and Notice of Meeting
25th Mar 20251:38 pmRNSDirector/PDMR Shareholding
25th Mar 202512:30 pmRNSHolding(s) in Company
24th Mar 20252:31 pmRNSHolding(s) in Company
14th Mar 20251:26 pmRNSHolding(s) in Company
12th Mar 20255:52 pmRNSHolding(s) in Company
12th Mar 20252:26 pmRNSHolding(s) in Company
11th Mar 20253:51 pmRNSDirector/PDMR Shareholding
6th Mar 20253:55 pmRNSHolding(s) in Company
6th Mar 20251:02 pmRNSDirector/PDMR Shareholding
6th Mar 20259:59 amRNSHolding(s) in Company
4th Mar 20255:15 pmRNSHolding(s) in Company
4th Mar 20251:56 pmRNSHolding(s) in Company
3rd Mar 20255:31 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.